Literature DB >> 16104132

Antireflux surgery in the setting of lung transplantation: strategies for treating gastroesophageal reflux disease in a high-risk population.

Matthew G Hartwig1, James Z Appel, R Duane Davis.   

Abstract

In lung transplant recipients, GERD is associated with increased incidence of acute rejection, earlier onset of chronic rejection, and higher mortality. Surgical treatment of GERD in lung recipients seems to prevent early allograft dysfunction and improve overall survival. A total (360 degrees) fundoplication is shown to be a safe and effective method for treating GERD in lung transplant recipients and is the authors' procedure of choice, in most cases, for this high-risk patient population. The principal goal should be to minimize reflux of enteric contents that may lead to micro- or macroaspiration events in this complicated group of patients. Perioperative care should involve a multidisciplinary approach, including physicians and other health care providers familiar with the complexities of lung transplant recipients.

Entities:  

Mesh:

Year:  2005        PMID: 16104132     DOI: 10.1016/j.thorsurg.2005.03.001

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  10 in total

Review 1.  Gastroesophageal reflux and altered motility in lung transplant rejection.

Authors:  J M Castor; R K Wood; A J Muir; S M Palmer; R A Shimpi
Journal:  Neurogastroenterol Motil       Date:  2010-05-26       Impact factor: 3.598

Review 2.  A review of the potential applications and controversies of non-invasive testing for biomarkers of aspiration in the lung transplant population.

Authors:  C S Davis; J Gagermeier; D Dilling; C Alex; E Lowery; E J Kovacs; R B Love; P M Fisichella
Journal:  Clin Transplant       Date:  2010-03-19       Impact factor: 2.863

Review 3.  Systemic sclerosis--challenges for clinical practice.

Authors:  Zsuzsanna H McMahan; Laura K Hummers
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

4.  Feasibility of laparoscopic Nissen fundoplication after pediatric lung or heart-lung transplantation: should this be the standard?

Authors:  Chi Zheng; Timothy D Kane; Geoffrey Kurland; Kathy Irlano; Jonathan Spahr; Douglas A Potoka; Peter D Weardon; Victor O Morell
Journal:  Surg Endosc       Date:  2010-06-29       Impact factor: 4.584

5.  Gastroesophageal reflux disease is associated with an increased rate of acute rejection in lung transplant allografts.

Authors:  N Shah; S D Force; P O Mitchell; E Lin; E C Lawrence; K Easley; J Qian; A Ramirez; D C Neujahr; A Gal; K Leeper; A Pelaez
Journal:  Transplant Proc       Date:  2010-09       Impact factor: 1.066

6.  Repetitive gastric aspiration leads to augmented indirect allorecognition after lung transplantation in miniature swine.

Authors:  Andrew J Meltzer; Matthew J Weiss; Gregory R Veillette; Hisashi Sahara; Choo Y Ng; Meghan E Cochrane; Stuart L Houser; David H Sachs; Bruce R Rosengard; Joren C Madsen; John C Wain; James S Allan
Journal:  Transplantation       Date:  2008-12-27       Impact factor: 4.939

7.  Antireflux surgery for patients with end-stage lung disease before and after lung transplantation.

Authors:  W J Gasper; M P Sweet; C Hoopes; L E Leard; M E Kleinhenz; S R Hays; J A Golden; M G Patti
Journal:  Surg Endosc       Date:  2007-08-18       Impact factor: 4.584

8.  Azithromycin reduces gastroesophageal reflux and aspiration in lung transplant recipients.

Authors:  V Mertens; K Blondeau; A Pauwels; R Farre; B Vanaudenaerde; R Vos; G Verleden; D E Van Raemdonck; L J Dupont; D Sifrim
Journal:  Dig Dis Sci       Date:  2009-02-25       Impact factor: 3.199

Review 9.  Impact of changing epidemiology of gastroesophageal reflux disease on its diagnosis and treatment.

Authors:  Hugo Bonatti; Sami R Achem; Ronald A Hinder
Journal:  J Gastrointest Surg       Date:  2008-02       Impact factor: 3.452

10.  GERD related micro-aspiration in chronic mustard-induced pulmonary disorder.

Authors:  Rasoul Aliannejad; Seyed-Mehdi Hashemi-Bajgani; Asharaf Karbasi; Mahvash Jafari; Jafar Aslani; Maryam Salehi; Mostafa Ghanei
Journal:  J Res Med Sci       Date:  2012-08       Impact factor: 1.852

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.